Yosuke Hirotsu

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 55

Top Topics

Small Cell Lung Cancer

Respiratory Syndrome Coronavirus

Top Venues

Scientific reports

Journal of gynecologic oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Nagakubo, Yosuke Hirotsu, Mona Yoshino, Kenji Amemiya, Ryota Saito, Yumiko Kakizaki, Toshiharu Tsutsui, Yoshihiro Miyashita, Taichiro Goto, Masao Omata
Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancer. Scientific reports 14 (1) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Yosuke Hirotsu, Yuki Nagakubo, Makoto Maejima, Masahiro Shibusawa, Kazuhiro Hosaka, Hitomi Sueki, Hitoshi Mochizuki, Masao Omata
Changes in Viral Dynamics Following the Legal Relaxation of COVID-19 Mitigation Measures in Japan From Children to Adults: A Single Center Study, 2020-2023. Influenza and other respiratory viruses 18 (3) (2024)
Yosuke Hirotsu, Takahiro Nakagomi, Yuki Nagakubo, Taichiro Goto, Masao Omata
Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions. Scientific reports 14 (1) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology (2024)
Yosuke Hirotsu, Takahiro Nakagomi, Yuki Nagakubo, Taichiro Goto, Masao Omata
Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions. Scientific reports 14 (1) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Yosuke Hirotsu, Takahiro Nakagomi, Yuki Nagakubo, Taichiro Goto, Masao Omata
Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions. Scientific reports 14 (1) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Yuki Nagakubo, Yosuke Hirotsu, Mona Yoshino, Kenji Amemiya, Ryota Saito, Yumiko Kakizaki, Toshiharu Tsutsui, Yoshihiro Miyashita, Taichiro Goto, Masao Omata
Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancer. Scientific reports 14 (1) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Yuki Nagakubo, Yosuke Hirotsu, Mona Yoshino, Kenji Amemiya, Ryota Saito, Yumiko Kakizaki, Toshiharu Tsutsui, Yoshihiro Miyashita, Taichiro Goto, Masao Omata
Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancer. Scientific reports 14 (1) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Kenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, Hitoshi Mochizuki, Toshio Oyama, Masao Omata
Influence of formalin fixation duration on RNA quality and quantity from formalin-fixed paraffin-embedded hepatocellular carcinoma tissues. Pathology international (2023)
Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Keiichiro Honma, Harumi Nakamura, Kazumi Nishino, Masao Omata
Genetic dissection of intratumor heterogeneity of PD-L1 expression in EGFR-mutated lung adenocarcinoma. Thoracic cancer (2023)
Yosuke Hirotsu, Yumiko Kakizaki, Akitoshi Saito, Toshiharu Tsutsui, Syunya Hanawa, Haruna Yamaki, Syuichiro Ide, Makoto Kawaguchi, Hiroaki Kobayashi, Yoshihiro Miyashita, Masao Omata
Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2. Communications medicine 3 (1) (2023)
Yosuke Hirotsu, Yumiko Kakizaki, Akitoshi Saito, Toshiharu Tsutsui, Syunya Hanawa, Haruna Yamaki, Syuichiro Ide, Makoto Kawaguchi, Hiroaki Kobayashi, Yoshihiro Miyashita, Masao Omata
Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2. Communications medicine 3 (1) (2023)
Yuki Nagakubo, Yosuke Hirotsu, Kenji Amemiya, Hitoshi Mochizuki, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Rumi Higuchi, Takahiro Nakagomi, Taichiro Goto, Toshio Oyama, Masao Omata
Nucleic Acid Quality Assessment is Critical to the Success of the Oncomine Dx Target Test for Lung Cancer. Molecular diagnosis & therapy (2023)
Yosuke Hirotsu, Yumiko Kakizaki, Akitoshi Saito, Toshiharu Tsutsui, Syunya Hanawa, Haruna Yamaki, Syuichiro Ide, Makoto Kawaguchi, Hiroaki Kobayashi, Yoshihiro Miyashita, Masao Omata
Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2. Communications medicine 3 (1) (2023)
Mai Okamoto, Makoto Maejima, Taichiro Goto, Takahiro Mikawa, Kazuhiro Hosaka, Yuki Nagakubo, Yosuke Hirotsu, Kenji Amemiya, Hitomi Sueki, Masao Omata
Impact of the FilmArray Rapid Multiplex PCR Assay on Clinical Outcomes of Patients with Bacteremia. Diagnostics (Basel, Switzerland) 13 (11) (2023)
Yosuke Hirotsu, Hiroki Sugiura, Mika Takatori, Hitoshi Mochizuki, Masao Omata
Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination. Microbiology spectrum (2023)
Kenichiro Okimoto, Yosuke Hirotsu, Makoto Arai, Kenji Amemiya, Naoki Akizue, Yuki Ohta, Takashi Taida, Keiko Saito, Hiroshi Ohyama, Tomoaki Matsumura, Motoi Nishimura, Kazuyuki Matsushita, Keisuke Matsusaka, Toshio Oyama, Hitoshi Mochizuki, Tetsuhiro Chiba, Jun Kato, Jun-Ichiro Ikeda, Osamu Yokosuka, Naoya Kato, Masao Omata
Validity of pathological diagnosis for early colorectal cancer in genetic background. Cancer medicine (2023)
Yosuke Hirotsu, Yumiko Kakizaki, Akitoshi Saito, Toshiharu Tsutsui, Syunya Hanawa, Haruna Yamaki, Syuichiro Ide, Makoto Kawaguchi, Hiroaki Kobayashi, Yoshihiro Miyashita, Masao Omata
Lung tropism in hospitalized patients following infection with SARS-CoV-2 variants from D614G to Omicron BA.2. Communications medicine 3 (1) (2023)
Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Rumi Higuchi, Takahiro Nakagomi, Taichiro Goto, Toshio Oyama, Tetsuo Kondo, Masao Omata
Deep targeted sequencing of cytological tumor cells using whole genome amplification. Cancer cytopathology (2022)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens. Cancer cytopathology 130 (8) (2022)
Kenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, Shunsuke Watanabe, Saki Amemiya, Hitoshi Mochizuki, Toshio Oyama, Tetsuo Kondo, Masao Omata
Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next-generation sequencing. Cancer medicine (2022)
Ikuko Sakamoto, Yosuke Hirotsu, Kenji Amemiya, Takahiro Nozaki, Hitoshi Mochizuki, Masao Omata
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis. Journal of gynecologic oncology (2022)
Sotaro Otake, Taichiro Goto, Rumi Higuchi, Takahiro Nakagomi, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
The Diagnostic Utility of Cell-Free DNA from Ex Vivo Bronchoalveolar Lavage Fluid in Lung Cancer. Cancers 14 (7) (2022)
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, Yume Natori, Yuki Nagakubo, Kazuhiro Hosaka, Hitomi Sueki, Kenji Amemiya, Miyoko Hayakawa, Hitoshi Mochizuki, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Masao Omata
Direct comparison of Xpert Xpress, FilmArray Respiratory Panel, Lumipulse antigen test, and RT-qPCR in 165 nasopharyngeal swabs. BMC infectious diseases 22 (1) (2022)
Yuki Nagakubo, Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, Kazuhiro Hosaka, Kenji Amemiya, Hitomi Sueki, Miyoko Hayakawa, Hitoshi Mochizuki, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Masao Omata
Non-pharmaceutical interventions during the COVID-19 epidemic changed detection rates of other circulating respiratory pathogens in Japan. PloS one 17 (1) (2022)
Naoki Akizue, Kenichiro Okimoto, Makoto Arai, Yosuke Hirotsu, Kenji Amemiya, Hirotaka Oura, Tatsuya Kaneko, Mamoru Tokunaga, Kentaro Ishikawa, Yuki Ohta, Takashi Taida, Keiko Saito, Daisuke Maruoka, Tomoaki Matsumura, Tomoo Nakagawa, Motoi Nishimura, Tetsuhiro Chiba, Kazuyuki Matsushita, Hitoshi Mochizuki, Osamu Yokosuka, Masao Omata, Naoya Kato
Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions. Cancer medicine 10 (11) (2021)
Yosuke Hirotsu, Masao Omata
Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan. PLoS pathogens 17 (6) (2021)
Rumi Higuchi, Taichiro Goto, Yosuke Hirotsu, Sotaro Otake, Toshio Oyama, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata
Streptococcus australis and Ralstonia pickettii as Major Microbiota in Mesotheliomas. Journal of personalized medicine 11 (4) (2021)
Kenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, Hitoshi Mochizuki, Rumi Higuchi, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Toshio Oyama, Masao Omata
Actionable driver DNA variants and fusion genes can be detected in archived cytological specimens with the Oncomine Dx Target Test Multi-CDx system in lung cancer. Cancer cytopathology 129 (9) (2021)
Hiroyuki Amano, Tatsuo Kanda, Hitoshi Mochizuki, Yuichiro Kojima, Yoji Suzuki, Kenji Hosoda, Hiroshi Ashizawa, Yuko Miura, Shotaro Tsunoda, Yosuke Hirotsu, Hiroshi Ohyama, Naoya Kato, Mitsuhiko Moriyama, Shuntaro Obi, Masao Omata
The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection. Viruses 13 (11) (2021)
Rumi Higuchi, Taichiro Goto, Yosuke Hirotsu, Sotaro Otake, Toshio Oyama, Kenji Amemiya, Hiroshi Ohyama, Hitoshi Mochizuki, Masao Omata
Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors. Journal of personalized medicine 11 (11) (2021)
Taichiro Goto, Kei Kunimasa, Yosuke Hirotsu, Takahiro Nakagomi, Yujiro Yokoyama, Rumi Higuchi, Sotaro Otake, Toshio Oyama, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata
Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer. Cancers 12 (11) (2020)
Yosuke Hirotsu, Sotaro Otake, Hiroshi Ohyama, Kenji Amemiya, Rumi Higuchi, Toshio Oyama, Hitoshi Mochizuki, Taichiro Goto, Masao Omata
Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma. Scientific reports 10 (1) (2020)
Rumi Higuchi, Taichiro Goto, Yosuke Hirotsu, Yujiro Yokoyama, Takahiro Nakagomi, Sotaro Otake, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
Primary Driver Mutations in GTF2I Specific to the Development of Thymomas. Cancers 12 (8) (2020)
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, Yuki Nagakubo, Kazuhiro Hosaka, Kenji Amemiya, Hitomi Sueki, Miyoko Hayakawa, Hitoshi Mochizuki, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Masao Omata
Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients. Scientific reports 10 (1) (2020)
Yosuke Hirotsu, Masao Hada, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer. Journal of gastroenterology 55 (5) (2020)
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Ryota Masuzaki, Mitsuhiko Moriyama, Masao Omata
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. International journal of molecular sciences 21 (4) (2020)
Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Yuki Nagakubo, Taichiro Goto, Yoshihiro Miyashita, Yumiko Kakizaki, Toshiharu Tsutsui, Sotaro Otake, Hiroaki Kobayashi, Rumi Higuchi, Kie Inomata, Takashi Kumagai, Hitoshi Mochizuki, Harumi Nakamura, Shin-Ichi Nakatsuka, Kazumi Nishino, Fumio Imamura, Toru Kumagai, Toshio Oyama, Masao Omata
Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer. Cancer medicine 9 (13) (2020)
Yosuke Hirotsu, Makoto Maejima, Masumi Nakajima, Hitoshi Mochizuki, Masao Omata
Environmental cleaning is effective for the eradication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in contaminated hospital rooms: A patient from the Diamond Princess cruise ship. Infection control and hospital epidemiology 41 (9) (2020)
Yosuke Hirotsu, Udo Schmidt-Edelkraut, Hiroshi Nakagomi, Ikuko Sakamoto, Markus Hartenfeller, Ram Narang, Theodoros G Soldatos, Sajo Kaduthanam, Xiaoyue Wang, Stephan Hettich, Stephan Brock, David B Jackson, Masao Omata
Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide. International journal of molecular sciences 21 (11) (2020)
Yosuke Hirotsu, Hitoshi Mochizuki, Kenji Amemiya, Hiroshi Ohyama, Dai Yoshimura, Hiroyuki Amano, Yuko Miura, Hiroshi Ashizawa, Keiko Nakagomi, Shinya Takaoka, Kenji Hosoda, Yoji Suzuki, Toshio Oyama, Masao Hada, Yuichiro Kojima, Masao Omata
Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer. Medical oncology (Northwood, London, England) 36 (3) (2019)
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. International journal of molecular sciences 20 (6) (2019)
Shinya Takaoka, Yosuke Hirotsu, Hiroshi Ohyama, Hitoshi Mochizuki, Kenji Amemiya, Toshio Oyama, Hiroshi Ashizawa, Dai Yoshimura, Keiko Nakagomi, Kenji Hosoda, Yoji Suzuki, Yuichiro Kojima, Masao Omata
Molecular subtype switching in early-stage gastric cancers with multiple occurrences. Journal of gastroenterology 54 (8) (2019)
Yuki Nagakubo, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR. BMC medical genomics 12 (1) (2019)
Yosuke Hirotsu, Hitoshi Yokoyama, Kenji Amemiya, Takashi Hagimoto, Hironori Daimon, Kyoko Hosaka, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer. Cancer science 110 (10) (2019)
Taichiro Goto, Yosuke Hirotsu, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata
Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach. Cancers 10 (7) (2018)
Takahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, Daichi Shikata, Yujiro Yokoyama, Rumi Higuchi, Sotaro Otake, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3. Cancers 10 (12) (2018)
Yosuke Hirotsu, Hiroshi Nakagomi, Kenji Amemiya, Toshio Oyama, Masayuki Inoue, Hitoshi Mochizuki, Masao Omata
Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient. Medical oncology (Northwood, London, England) 34 (1) (2016)
Taichiro Goto, Yosuke Hirotsu, Toshio Oyama, Kenji Amemiya, Masao Omata
Analysis of tumor-derived DNA in plasma and bone marrow fluid in lung cancer patients. Medical oncology (Northwood, London, England) 33 (3) (2016)
Kenji Amemiya, Yosuke Hirotsu, Taichiro Goto, Hiroshi Nakagomi, Hitoshi Mochizuki, Toshio Oyama, Masao Omata
Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumors. Cancer medicine 5 (12) (2016)